Related Experiment Video
Updated: Aug 7, 2026

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
Published on: December 30, 2016
Stabilisation of plasma substrate concentrations: A model for conducting metabolic studies
Y A Carpentier1, M Richelle, M Rubin
1Clinical Nutrition Unit, Hôpital Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium.
Abstract:
Metabolic studies involving changes in plasma substrate concentrations are frequently carried out after an overnight fast. This condition, however, is a transition between the post-prandial period and the beginning of starvation, and thus is associated with rapid changes in the plasma concentration of many substrates. Such alterations might interfere with the interpretation of modifications in plasma concentrations resulting from experimental manipulations. Infusion of glucose at a rate of 250 mg kg(-1) h(-1) for 1h and subsequently at 162 mg kg(-1) h(-1) together with amino-acids at 50 mg kg(-1) h(-1) is used to stabilise the plasma concentration of most substrates within 3 h, a condition which is maintained for the subsequent 5 h or more. This study offers a model which is more suitable for many metabolic investigations than overnight fasting and which takes little time or expense to prepare.
Related Concept Videos
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Steady State Concentration
Most drugs are administered in repeated doses at fixed intervals or through continuous intravenous...
Model Approaches for Pharmacokinetic Data: Physiological Models
Pharmacodynamic Models: Linear Concentration–Effect Model

